Table 2.
Characteristics of decolonized patients with successful and unsuccessful decolonization outcome (n = 268)
Successful decolonization | Unsuccessful decolonization | OR (95 % CI) | P | |
---|---|---|---|---|
(n = 104) | (n = 164) | |||
Presence of wound | 14 (13.64) | 71 (83.53) | 4.9 (2.5–9.3) | <.00001 |
≥2 sites | 38 (36.5) | 90 (54.8) | 0.4 (0.2–0.7) | .003 |
Only nose | 30 (28.8) | 11 (6.71) | 0.3 (0.2–0.6) | <.00001 |
Mupirocin resistance | 3 (2.8) | 18 (10.98) | 4.1 (1.1–14.4) | .001 |
Mupirocin R (high level of resistance) | 1 (0.96) | 8 (4.88) | 5.2 (0.65–42.8) | <.00001 |
Mupirocin I (low level of resistance) | 2 (1.9) | 10 (6.1) | 3.3 (0.7–15.4) | .10 |
Subsequent MRSA Infection | 0 (0) | 8 (4.8) | Undefined | .002 |
Time period: days from the end of treatment to infection average: 76.25 median: 43.50 (rang: 2–258)
Note: data are no (%) of patients